Funeng Xu
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biotechnology top 2%
- Cancer Research and Treatments
Papers in
-
- Bacterial biofilms and quorum sensing 5
-
- Nanoplatforms for cancer theranostics 9
- Co-authors
- Xuehui Huang (7 shared papers)Shaobing Zhou (10 shared papers)Yi Wang (5 shared papers)Jingmei Pan (5 shared papers)Guoqing Wei (2 shared papers)Xing Guo (2 shared papers)Yi Wang (1 shared paper)Xiaobin Zhang (1 shared paper)
- Journals
- Advanced Materials (4 papers)Bioorganic Chemistry (4 papers)International Journal of Molecular Sciences (3 papers)Molecules (2 papers)Advanced Functional Materials (2 papers)
- Partner nations
- ChinaUnited StatesMaldives
In The Last Decade
Funeng Xu
53 papers receiving 1.6k citations
Funeng Xu's Hit Papers
Peers
Comparison fields: 5 of 107
- Biomaterials 418
- Biotechnology 236
- Biomedical Engineering 871
- Rehabilitation 61
- Molecular Medicine 46
Countries citing papers authored by Funeng Xu
This map shows the geographic impact of Funeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Funeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Funeng Xu more than expected).
Fields of papers citing papers by Funeng Xu
This network shows the impact of papers produced by Funeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Funeng Xu. The network helps show where Funeng Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Funeng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bacteria‐Based Cancer Immunotherapy Hit paper breakdown → | 2021 | 240 |
| 2 | 2017 | 193 | |
| 3 | 2020 | 191 | |
| 4 | 2019 | 140 | |
| 5 | 2021 | 114 | |
| 6 | 2020 | 88 | |
| 7 | 2021 | 66 | |
| 8 | 2019 | 62 | |
| 9 | 2016 | 60 | |
| 10 | 2021 | 57 | |
| 11 | 2020 | 50 | |
| 12 | 2022 | 48 | |
| 13 | 2021 | 40 | |
| 14 | 2022 | 31 | |
| 15 | 2022 | 23 | |
| 16 | 2020 | 19 | |
| 17 | 2022 | 14 | |
| 18 | 2022 | 13 | |
| 19 | 2023 | 12 | |
| 20 | 2022 | 10 |
About Funeng Xu
Funeng Xu is a scholar working on Molecular Biology, Biomedical Engineering, Materials Chemistry, Organic Chemistry and Rehabilitation, having authored 60 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), Crystallization and Solubility Studies (6 papers), Antibiotic Resistance in Bacteria (5 papers), Bacterial biofilms and quorum sensing (5 papers), Wound Healing and Treatments (5 papers), Chemical and Physical Properties in Aqueous Solutions (4 papers), Pharmacological Effects of Natural Compounds (4 papers) and Photodynamic Therapy Research Studies (3 papers). The work is most often cited by research in Biomaterials (418 citations), Biotechnology (236 citations), Biomedical Engineering (871 citations), Rehabilitation (61 citations) and Molecular Medicine (46 citations). Funeng Xu has collaborated with scholars based in China, United States and Maldives. Frequent co-authors include Xuehui Huang, Shaobing Zhou, Yi Wang, Jingmei Pan, Guoqing Wei, Xing Guo, Yi Wang, Xiaobin Zhang, Xiang Xiong and Haohuan Li. Their work appears in journals such as Advanced Materials, Bioorganic Chemistry, International Journal of Molecular Sciences, Molecules and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.